HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Costimulatory and Inhibitory T-Cell Receptors

A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.
Also Known As:
Costimulatory T-Cell Receptors; Costimulatory T-Lymphocyte Receptors; Costimulatory and Inhibitory T-Lymphocyte Receptors; Inhibitory T-Cell Receptors; Inhibitory T-Lymphocyte Receptors; Receptors, Costimulatory and Inhibitory, T-Lymphocyte; Receptors, Costimulatory, T-Lymphocyte; Receptors, Inhibitory, T-Cell; Costimulatory T Cell Receptors; Costimulatory T Lymphocyte Receptors; Costimulatory and Inhibitory T Cell Receptors; Costimulatory and Inhibitory T Lymphocyte Receptors; Inhibitory T Cell Receptors; Inhibitory T Lymphocyte Receptors; Receptors, Costimulatory T-Cell; Receptors, Costimulatory T-Lymphocyte; Receptors, Inhibitory T-Cell; Receptors, Inhibitory T-Lymphocyte; T-Cell Receptors, Costimulatory; T-Cell Receptors, Inhibitory; T-Lymphocyte Receptors, Costimulatory; T-Lymphocyte Receptors, Inhibitory
Networked: 9 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Chee, Jonathan: 1 article (01/2021)
2. Chen, Hui: 1 article (01/2021)
3. Huang, Jian-An: 1 article (01/2021)
4. Kidman, Joel: 1 article (01/2021)
5. Lake, Richard A: 1 article (01/2021)
6. Lesterhuis, Willem Joost: 1 article (01/2021)
7. Li, Jin: 1 article (01/2021)
8. McDonnell, Alison M: 1 article (01/2021)
9. Nowak, Anna K: 1 article (01/2021)
10. Pang, Yu: 1 article (01/2021)

Related Diseases

1. Neoplasms (Cancer)
10/11/2022 - "However, therapeutic targeting of inhibitory T cell receptors such as PD-1 not only initiates a broad immune response against tumors, but also causes severe adverse effects. "
01/01/2015 - "Antibodies that stimulate the immune system by targeting inhibitory T cell receptors were successfully introduced into oncological practice and are capable to overcome tumor-induced immune evasion. "
01/01/2021 - "The success of immunotherapy that targets inhibitory T cell receptors for the treatment of multiple cancers has seen the anti-tumor immune response re-emerge as a promising biomarker of response to therapy. "
01/01/2011 - "Targeting coinhibitory and costimulatory T cell receptors with specific antibodies in cancer patients is an emerging approach to T cell manipulation, namely "immune modulation." Cytotoxic T-lymphocyte antigen-4 (CTLA-4) and glucocorticoid-induced tumor necrosis factor family receptor (GITR) are potential targets for immune modulation through anti-CTLA-4 blocking antibodies and anti-GITR agonistic antibodies, respectively. "
11/15/2016 - "However, biomarkers and assays development to guide cancer immunotherapy is highly challenging for several reasons: (i) multiplicity of immunotherapy agents with different mechanisms of action including immunotherapies that target activating and inhibitory T cell receptors (e.g., CTLA-4, PD-1, etc.); adoptive T cell therapies that include tissue infiltrating lymphocytes (TILs), chimeric antigen receptors (CARs), and T cell receptor (TCR) modified T cells; (ii) tumor heterogeneity including changes in antigenic profiles over time and location in individual patient; and (iii) a variety of immune-suppressive mechanisms in the tumor microenvironment (TME) including T regulatory cells (Treg), myeloid derived suppressor cells (MDSC) and immunosuppressive cytokines. "
2. Infections
3. Alcoholic Fatty Liver
4. Persistent Infection
5. Squamous Cell Carcinoma of Head and Neck

Related Drugs and Biologics

1. Biomarkers (Surrogate Marker)
2. Antibodies
3. Programmed Cell Death 1 Receptor
4. Blocking Antibodies
5. Cytokines
6. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
7. T-Cell Antigen Receptors (T-Cell Receptor)
8. Glucocorticoids
9. DNA (Deoxyribonucleic Acid)
10. Chimeric Antigen Receptors

Related Therapies and Procedures

1. Therapeutics
2. Immunotherapy